Home2BO • FRA
add
Serina Therapeutics Inc
Previous close
€4.80
Day range
€4.64 - €4.78
Year range
€1.86 - €8.50
Market cap
57.77M USD
Avg Volume
13.00
P/E ratio
-
Dividend yield
-
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.91M | 138.28% |
Net income | -4.81M | 67.95% |
Net profit margin | — | — |
Earnings per share | -0.49 | — |
EBITDA | -5.84M | -154.40% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.27M | -50.99% |
Total assets | 6.73M | -38.00% |
Total liabilities | 5.17M | -65.90% |
Total equity | 1.56M | — |
Shares outstanding | 9.97M | — |
Price to book | 28.24 | — |
Return on assets | -217.69% | — |
Return on capital | -996.26% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -4.81M | 67.95% |
Cash from operations | -4.32M | -174.06% |
Cash from investing | — | — |
Cash from financing | 4.92M | 80.24% |
Net change in cash | 595.00K | -47.67% |
Free cash flow | -2.18M | -280.37% |
About
Founded
2006
Headquarters
Website
Employees
13
